INS and metabolic syndrome: Obesity or visceral obesity has been found to potentially contribute to the upregulation of adipocytokines, and heightened inflammatory activity, ultimately leading to diminished insulin sensitivity, dyslipidemia, endothelial dysfunction, development of atherosclerosis, and increased stiffness.31, 32, 33